This invention provides novel dihydropyridine derivatives of the formula I
having protein tyrosine kinase inhibitory activity, to process for the manufacture thereof and to the use thereof for the treatment of c-Met-mediated diseases or c-Met-mediated conditions.
本发明提供了一种具有
蛋白酪氨酸激酶抑制活性的新型二
氢吡啶衍生物,以及其制造方法和用于治疗c-Met介导的疾病或c-Met介导的病状的用途。